Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study

Table 3 Esophageal symptoms in SSc (N=56) and morphea (N=31)

	Mild symptoms	Moderate symptoms	Severe symptoms	Total symptomatic	P value, significance
Limited SSc (N=40)	15	9	1	25 (62.5%)	0.129 (Not Sig.)
Diffuse SSc (N=16)	7	5	2	14 (87.5%)	0.129 (Not Sig.)
Total SSc	22	14	3	39 (69.6%)	<0.001 (Sig.)
Morphea	4	0	0	04 (12.9%)	<0.001 (Sig.)

ISSN: 1471-230X